Krsnaa Diagnostics Ltd (KRSNAA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003520, "name": "Krsnaa Diagnost.", "stock_name": "Krsnaa Diagnost.", "full_name": "Krsnaa Diagnostics Ltd", "name_url": "stocks-analysis/krsnaa-diagnost", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "705.70", "chg": -16.75, "chgp": "-2.32%", "dir": -1, "prev_price": "722.45", "mcapval": "2,254.00 Cr", "mcap": "Small Cap", "scripcode": 543328, "symbol": "KRSNAA", "ind_name": "Healthcare Services", "ind_code": 94, "indexname": "", "isin": "INE08LI01020", "curr_date": "Feb 06", "curr_time": "", "bse_nse_vol": "1.9 lacs", "exc_status": "Active", "traded_date": "Feb 06, 2026", "traded_date_str": "2026 02 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/krsnaa-diagnost-1003520-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Krsnaa Diagnostics Declines 1.43%: Valuation Shifts and Market Volatility Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-declines-143-valuation-shifts-and-market-volatility-shape-the-week-3825926", "imagepath": "", "date": "2026-02-07 11:02:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens at Rs.697.80, down 1.73% amid broader market weakness</p>\n <p><strong>3 Feb:</strong> Sharp rebound to Rs.716.80 (+2.72%) supported by positive market sentiment</p>\n <p><strong>5 Feb:</strong> Q3 FY26 results reveal growth momentum but raise profitability concerns</p>\n <p><strong>6 Feb:</strong> Significant gap down opening at Rs.699.90 (-3.12%) amid market concerns</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\">\n <div class=\"stat-label\">Week Open</div>\n <div class=\"stat-value\">Rs.710.05</..." }, { "title": "Are Krsnaa Diagnostics Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-krsnaa-diagnostics-ltd-latest-results-good-or-bad-3824949", "imagepath": "", "date": "2026-02-06 19:30:28", "description": "Krsnaa Diagnostics Ltd's latest financial results indicate a significant shift in operational performance, characterized by declining profitability and increasing operational challenges. In the quarter ended December 2025, the company reported a net profit of ₹15.25 crores, reflecting a notable decline of 36.33% compared to the previous quarter. This downturn in profitability is concerning, especially as it follows a period of revenue growth, which saw net sales of ₹181.20 crores, down 12.03% from the previous quarter.\n\nThe operating profit margin also contracted to 25.63%, a decrease from 28.72% in the prior quarter. This margin compression is attributed to rising costs, particularly in employee expenses and depreciation, which have strained operational efficiency. Additionally, interest costs have risen, further impacting the company's financial health.\n\nOverall, Krsnaa Diagnostics has demonstrated robust..." }, { "title": "Krsnaa Diagnostics Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-ltd-is-rated-strong-sell-3824092", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrsnaaDiagnosti_mojoScore_3824092.png", "date": "2026-02-06 10:10:50", "description": "Krsnaa Diagnostics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance." }, { "title": "Krsnaa Diagnostics Ltd Opens with Significant Gap Down Amid Market Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-ltd-opens-with-significant-gap-down-amid-market-concerns-3823843", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrsnaaDiagnosti_gapdown_3823843.png", "date": "2026-02-06 09:31:08", "description": "Krsnaa Diagnostics Ltd commenced trading today with a pronounced gap down, opening 5.18% lower than its previous close, reflecting heightened market apprehension following recent developments. The stock’s weak start underscores ongoing pressures within the healthcare services sector, as investors reacted to overnight news and technical indicators signalling caution." }, { "title": "Krsnaa Diagnostics Q3 FY26: Growth Momentum Masks Deteriorating Profitability Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/krsnaa-diagnostics-q3-fy26-growth-momentum-masks-deteriorating-profitability-concerns-3823349", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrsnaaDiagnosti_quaterlyResult_3823349.png", "date": "2026-02-05 21:03:48", "description": "Krsnaa Diagnostics Ltd., a prominent player in India's diagnostic imaging and pathology services sector with a market capitalisation of ₹2,352 crores, delivered mixed results in Q2 FY26 (Jul-Sep'25), posting a consolidated net profit of ₹20.52 crores, down 0.77% quarter-on-quarter but up 14.51% year-on-year. Whilst the company demonstrated resilient top-line growth with revenues reaching ₹192.98 crores (up 3.71% QoQ and 13.36% YoY), the stock has faced significant headwinds, declining 17.92% over the past year and currently trading at ₹723.00, approximately 21% below its 52-week high of ₹914.95." }, { "title": "Krsnaa Diagnostics Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-ltd-valuation-shifts-signal-renewed-price-attractiveness-3821633", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrsnaaDiagnosti_valuationdot_3821633.png", "date": "2026-02-05 08:02:14", "description": "Krsnaa Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions and underlying financial metrics. Despite a challenging sector backdrop and mixed returns relative to the Sensex, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling entry point for discerning investors seeking exposure to healthcare services." }, { "title": "When is the next results date for Krsnaa Diagnostics Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-krsnaa-diagnostics-ltd-3810296", "imagepath": "", "date": "2026-01-29 23:16:46", "description": "The next results date for Krsnaa Diagnostics Ltd is scheduled for February 5, 2026...." }, { "title": "Krsnaa Diagnostics Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-ltd-is-rated-sell-3804714", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrsnaaDiagnosti_mojoScore_3804714.png", "date": "2026-01-26 10:10:05", "description": "Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Krsnaa Diagnostics Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-ltd-is-rated-sell-3792911", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrsnaaDiagnosti_mojoScore_3792911.png", "date": "2026-01-15 10:10:03", "description": "Krsnaa Diagnostics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 December 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 15 January 2026, providing investors with the latest comprehensive view." } ], "total": 275, "sid": "1003520", "stock_news_url": "https://www.marketsmojo.com/news/krsnaa-diagnostics-1003520" }, "announcements": [ { "caption": "List Of The Key Managerial PersonnelS (Kmps) For The Purpose Of Determining The Materiality Of An Event Or Information & Making Disclosures To The Stock Exchange(S).", "datetime": "05-Feb-2026", "details": "List of KMPs for the purpose of determining the materiality of an event.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Meeting Held On February 05 2026.", "datetime": "05-Feb-2026", "details": "Outcome of Board Meeting.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "05-Feb-2026", "details": "Press Release for quarter and nine months ended December 31 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Krsnaa Diagnostics Ltd has declared <strong>55%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Stock opens at Rs.697.80, down 1.73% amid broader market weakness

3 Feb: Sharp rebound to Rs.716.80 (+2.72%) supported by positive market sentiment

5 Feb: Q3 FY26 results reveal growth momentum but raise profitability concerns

6 Feb: Significant gap down opening at Rs.699.90 (-3.12%) amid market concerns

Week Open

Rs.710.05Read full news article

Are Krsnaa Diagnostics Ltd latest results good or bad?

2026-02-06 19:30:28

Krsnaa Diagnostics Ltd's latest financial results indicate a significant shift in operational performance, characterized by declining profitability and increasing operational challenges. In the quarter ended December 2025, the company reported a net profit of ₹15.25 crores, reflecting a notable decline of 36.33% compared to the previous quarter. This downturn in profitability is concerning, especially as it follows a period of revenue growth, which saw net sales of ₹181.20 crores, down 12.03% from the previous quarter. The operating profit margin also contracted to 25.63%, a decrease from 28.72% in the prior quarter. This margin compression is attributed to rising costs, particularly in employee expenses and depreciation, which have strained operational efficiency. Additionally, interest costs have risen, further impacting the company's financial health. Overall, Krsnaa Diagnostics has demonstrated robust...

Read full news article

Krsnaa Diagnostics Ltd is Rated Strong Sell

2026-02-06 10:10:50

Krsnaa Diagnostics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.

Read full news article

Krsnaa Diagnostics Ltd Opens with Significant Gap Down Amid Market Concerns

2026-02-06 09:31:08

Krsnaa Diagnostics Ltd commenced trading today with a pronounced gap down, opening 5.18% lower than its previous close, reflecting heightened market apprehension following recent developments. The stock’s weak start underscores ongoing pressures within the healthcare services sector, as investors reacted to overnight news and technical indicators signalling caution.

Read full news article

Krsnaa Diagnostics Q3 FY26: Growth Momentum Masks Deteriorating Profitability Concerns

2026-02-05 21:03:48

Krsnaa Diagnostics Ltd., a prominent player in India's diagnostic imaging and pathology services sector with a market capitalisation of ₹2,352 crores, delivered mixed results in Q2 FY26 (Jul-Sep'25), posting a consolidated net profit of ₹20.52 crores, down 0.77% quarter-on-quarter but up 14.51% year-on-year. Whilst the company demonstrated resilient top-line growth with revenues reaching ₹192.98 crores (up 3.71% QoQ and 13.36% YoY), the stock has faced significant headwinds, declining 17.92% over the past year and currently trading at ₹723.00, approximately 21% below its 52-week high of ₹914.95.

Read full news article

Krsnaa Diagnostics Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-02-05 08:02:14

Krsnaa Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions and underlying financial metrics. Despite a challenging sector backdrop and mixed returns relative to the Sensex, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling entry point for discerning investors seeking exposure to healthcare services.

Read full news article

When is the next results date for Krsnaa Diagnostics Ltd?

2026-01-29 23:16:46

The next results date for Krsnaa Diagnostics Ltd is scheduled for February 5, 2026....

Read full news article

Krsnaa Diagnostics Ltd is Rated Sell

2026-01-26 10:10:05

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Krsnaa Diagnostics Ltd is Rated Sell

2026-01-15 10:10:03

Krsnaa Diagnostics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 December 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 15 January 2026, providing investors with the latest comprehensive view.

Read full news article